Widening Disparities in Teen HPV Vaccinations during COVID-19 Pandemic: A Case Study from Veneto Region (Italy).

HPV adolescent vaccination coverage

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
11 Dec 2022
Historique:
received: 10 11 2022
revised: 29 11 2022
accepted: 08 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

In Local Health Unit 7, human papilloma virus (HPV) vaccination campaigns for 12-year-olds have long been implemented by the vaccination services of the Department of Prevention. Due to the pressure of the COVID-19 pandemic on these services, an emergency vaccination campaign was directly managed by primary care pediatricians (PCPs). An initial evaluation of this experience was conducted. Data on 12-year-olds assisted by PCPs belonging to the 2006 (pre-pandemic) and 2008 (pandemic) birth cohorts were extracted, along with HPV vaccination data. Health district, gender, citizenship, socioeconomic status, and PCPs were evaluated as possible influencing factors in a two-level logistic regression (second level: single PCP). The HPV vaccination gap between males and females increased significantly for the 2008 birth cohort compared to the 2006 birth cohort (11 vs. 4 percentage points). As for PCPs, the vaccination uptake range was 4-71% for the 2008 birth cohort vs. 32-85% for the 2006 cohort. The proportion of variance explained at the second level was overall equal to 9.7% for the 2008 cohort vs. 3.6% for the 2006 cohort. The vaccination campaign carried out during the peak of the COVID-19 pandemic increased the HPV vaccination gaps among Health Districts, genders, and individual PCPs, probably due to a lack of homogeneity in professional practices and attitudes toward HPV vaccination. Catch-up interventions are required in the immediate term, while an equity-lens approach should be taken for reprogramming the vaccination campaign. Greater involvement of schools and families could ensure a more equitable approach and a better uptake.

Identifiants

pubmed: 36560530
pii: vaccines10122120
doi: 10.3390/vaccines10122120
pmc: PMC9782394
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Vaccine. 2022 Apr 26;40(19):2656-2666
pubmed: 35367068
Pediatrics. 2017 Jan;139(1):
pubmed: 27940512
Vaccine. 2015 Sep 22;33(39):5188-95
pubmed: 26254978
Vaccine. 2021 May 12;39(20):2731-2735
pubmed: 33875269
J Adolesc Health. 2020 Nov;67(5):633-634
pubmed: 32933839
Prev Med. 2017 Feb;95:26-37
pubmed: 27932052
PLoS One. 2018 Mar 29;13(3):e0194920
pubmed: 29596515
PLoS One. 2012;7(9):e43416
pubmed: 23028452
Vaccines (Basel). 2022 Jun 24;10(7):
pubmed: 35891177
JAMA Pediatr. 2021 Sep 1;175(9):901-910
pubmed: 34028494
PLoS One. 2016 Apr 27;11(4):e0153778
pubmed: 27120054
J Epidemiol Community Health. 2014 Jan;68(1):57-63
pubmed: 23986492
Euro Surveill. 2013 Sep 26;18(39):
pubmed: 24094062
BMJ Open. 2018 Apr 20;8(4):e019206
pubmed: 29678965
Pediatrics. 2021 Jul;148(1):
pubmed: 33858983
Vaccine. 2014 Jul 16;32(33):4171-8
pubmed: 24886960
Prev Chronic Dis. 2022 Mar 31;19:E15
pubmed: 35358035
Int J Epidemiol. 2013 Jun;42(3):896-908
pubmed: 23620381
Pediatrics. 2019 Jan;143(1):
pubmed: 30530637
Epidemiol Prev. 2020 Mar-Jun;44(2-3):162-170
pubmed: 32631016
Matern Child Health J. 2016 Dec;20(12):2539-2547
pubmed: 27473091
J Epidemiol Community Health. 2017 Jan;71(1):87-97
pubmed: 27535769
Br J Gen Pract. 2011 Jul;61(588):e379-85
pubmed: 21722444
Arch Dis Child. 2022 Mar;107(3):e4
pubmed: 34285000
JAMA Pediatr. 2018 May 7;172(5):e180016
pubmed: 29507952
Int J Environ Res Public Health. 2020 Jul 25;17(15):
pubmed: 32722442
Curr Pharm Des. 2020;26(3):326-342
pubmed: 31942852
Pediatrics. 2019 Oct;144(4):
pubmed: 31527175
Arch Dis Child. 2022 Aug;107(8):733-739
pubmed: 35361613
BMJ Open. 2015 May 19;5(5):e006422
pubmed: 25991445
Vaccine. 2013 Apr 18;31 Suppl 2:B103-7
pubmed: 23598470
BMC Public Health. 2021 Oct 12;21(1):1848
pubmed: 34641851
Lancet Glob Health. 2022 Feb;10(2):e186-e194
pubmed: 34951973
Vaccines (Basel). 2021 Nov 23;9(12):
pubmed: 34960120
Vaccine. 2022 Mar 15;40(12):1790-1798
pubmed: 35164987

Auteurs

Luca Perin (L)

Department of Prevention of Local Health Unit n. 7, Veneto Region, 31011 Venice, Italy.

Alessandra Dal Zotto (A)

Department of Prevention of Local Health Unit n. 7, Veneto Region, 31011 Venice, Italy.

Marta Savio (M)

Post-Graduate School of Hygiene and Preventive Medicine, Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy.

Antonio Stano (A)

Department of Prevention of Local Health Unit n. 7, Veneto Region, 31011 Venice, Italy.

Lorenzo Bulegato (L)

Department of Prevention of Local Health Unit n. 7, Veneto Region, 31011 Venice, Italy.

Luca Tribbia (L)

Department of Prevention of Local Health Unit n. 7, Veneto Region, 31011 Venice, Italy.

Roberta Donà (R)

Department of Prevention of Local Health Unit n. 7, Veneto Region, 31011 Venice, Italy.

Matilde Tomasi (M)

Department of Prevention of Local Health Unit n. 7, Veneto Region, 31011 Venice, Italy.

Silvia Fietta (S)

Department of Prevention of Local Health Unit n. 7, Veneto Region, 31011 Venice, Italy.

Antonio Ferro (A)

Italian Society of Hygiene, Preventive Medicine and Public Health, 10126 Torino, Italy.

Vincenzo Baldo (V)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy.

Mario Saugo (M)

Department of Prevention of Local Health Unit n. 7, Veneto Region, 31011 Venice, Italy.

Silvia Cocchio (S)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, 35122 Padova, Italy.

Classifications MeSH